Neurocrine Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NBIX Nasdaq 2836 http://www.neurocrine.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neurocrine Biosciences, Inc.

Do Options Traders Know Something About Neurocrine Biosciences (NBIX) Stock We Don't? - Dec 14th, 2018 6:37 am
Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Synergy Pharmaceuticals - Dec 13th, 2018 4:55 am
Why Under Armour, Neurocrine Biosciences, and XPO Logistics Slumped Today - Dec 12th, 2018 2:35 pm
Why Neurocrine Biosciences Is Tanking - Dec 12th, 2018 10:49 am
Why Neurocrine Biosciences Stock Is Plummeting Today - Dec 12th, 2018 10:19 am
Neurocrine Biosciences says trial of Tourette syndrome treatment missed primary goal - Dec 12th, 2018 5:39 am
Neurocrine Biosciences Announces Topline Data from Phase IIb T-Force GOLD Study Demonstrating Valbenazine Did Not Meet Primary Endpoint in Pediatric Patients with Tourette Syndrome - Dec 12th, 2018 5:30 am
Should You Buy Neurocrine Biosciences, Inc. (NBIX)? - Dec 9th, 2018 1:31 am
See what the IHS Markit Score report has to say about Neurocrine Biosciences Inc. - Dec 6th, 2018 6:03 am
3 Top Biotech Stocks to Buy Right Now - Nov 27th, 2018 5:15 am
Edited Transcript of NBIX earnings conference call or presentation 5-Nov-18 9:30pm GMT - Nov 17th, 2018 1:53 pm
Neurocrine (NBIX) Catches Eye: Stock Jumps 6.5% - Nov 16th, 2018 7:04 am
Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Amarin - Nov 15th, 2018 5:00 am
AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress - Nov 14th, 2018 3:35 pm
5 Pharma Stocks to Stay Away From - Nov 12th, 2018 1:16 pm
Report: Developing Opportunities within Louisiana-Pacific, Neurocrine Biosciences, Tahoe Resources, Loews, Quotient Technology, and Evolent Health — Future Expectations, Projections Moving into 2018 - Nov 9th, 2018 6:30 am
Neurocrine Biosciences to Present at the Jefferies 2018 London Healthcare Conference - Nov 7th, 2018 2:01 pm
Does Neurocrine Biosciences Inc’s (NASDAQ:NBIX) Debt Level Pose A Problem? - Nov 7th, 2018 10:17 am